retatrutide type 2 diabetes trial results 🚨 Today, retatrutide, the GIP/GLP-1/glucagon triple agonist, just delivered TRIUMPH-2 top-line results. A study in those with concurrent obesity and diabetes. 📊 Mean body weight change at 80 weeks: ⬇️ New Kind of Diabetes Drug

E.ButricoG

The neurotransmitters glycine and GABA stimulate glucagon-like peptide-1 release from the GLUTag cell line

Front Endocrinol 13:975912 Tomlinson B, Patil NG, Fok M, Chan P, Lam CWK (2022) The role of sulfonylureas in the treatment of type 2 diabetes

Keep away from sunlight and protected from strong odors

If youre taking insulin or other medications to lower your blood sugar, be extra cautious when using Semaglutide

For those who qualify, Noom Med, Noom Microdose GLP-1 Rx , and Noom + HRT rx provide enhanced support via medical weight-loss or hormone therapy optionseach integrated with Nooms habit-change framework